Allopurinol and Pulmonary vascular disorder - a phase IV clinical study of FDA data

Summary:

Pulmonary vascular disorder is reported as a side effect among people who take Allopurinol (allopurinol), especially for people who are male, 60+ old, also take Clopidogrel, and have Infective exacerbation of chronic obstructive airways disease.

The phase IV clinical study analyzes which people have Pulmonary vascular disorder when taking Allopurinol. It is created by eHealthMe based on reports of 188,106 people who have side effects when taking Allopurinol from the FDA, and is updated regularly.

What is Allopurinol?

Allopurinol has active ingredients of allopurinol. It is often used in gout. eHealthMe is studying from 190,868 Allopurinol users. Check the latest studies of Allopurinol.

What is Pulmonary vascular disorder?

Pulmonary vascular disorder is found to be associated with 225 drugs and 234 conditions by eHealthMe. Check the latest studies of Pulmonary vascular disorder.

On Jul, 26, 2026

188,106 people reported to have side effects when taking Allopurinol.
Among them, 46 people (0.02%) have Pulmonary vascular disorder.

Could Allopurinol cause Pulmonary vascular disorder?

Among these 46 people:

What is the gender of people who have Pulmonary vascular disorder when taking Allopurinol? *

female: 6.82 %
male: 93.18 %

What is the age of people who have Pulmonary vascular disorder when taking Allopurinol? *

What are other drugs people take besides Allopurinol? *

What are other side effects people have besides Pulmonary vascular disorder? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 41 people, 89.13%
Oedema Peripheral (superficial swelling): 40 people, 86.96%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 40 people, 86.96%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 39 people, 84.78%
Gastritis (inflammation of stomach): 39 people, 84.78%
Duodenitis (inflammation of the duodenum): 39 people, 84.78%
Chest Pain: 39 people, 84.78%
Cardiac Failure: 39 people, 84.78%
Weakness: 39 people, 84.78%
Skin Ulcer: 38 people, 82.61%

What are the existing conditions these people have? *

Infective Exacerbation Of Chronic Obstructive Airways Disease (severe infective lung disease with chronic obstructive airways disease): 32 people, 69.57%
Heart Attack: 10 people, 21.74%
Type 2 Diabetes: 1 person, 2.17%
Stress And Anxiety: 1 person, 2.17%
Cardiac Disorder: 1 person, 2.17%
Cardiac Failure Congestive: 1 person, 2.17%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 2.17%
High Blood Pressure: 1 person, 2.17%
Hypersensitivity: 1 person, 2.17%
Insomnia (sleeplessness): 1 person, 2.17%

* Approximation only. Some reports may have incomplete information.

Do you take Allopurinol and have Pulmonary vascular disorder?

- Check whether Pulmonary vascular disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Allopurinol:

Allopurinol (190,868 reports)

Browse all side effects of Allopurinol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary vascular disorder:

Pulmonary vascular disorder (225 drugs)

Browse all the conditions that are associated with Pulmonary vascular disorder:

Pulmonary vascular disorder (234 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on allopurinol (the active ingredients of Allopurinol) and Allopurinol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.